OppenheimerFunds’s AstraZeneca AZN Stock Holding History

OppenheimerFunds’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$166M	Buy	2,052,645 +1,201,960	+141%	+$94.7M	0.21%	111
2018 Q4	$64.6M	Buy	850,685 +594,695	+232%	+$46.4M	0.09%	217
2018 Q3	$20.3M	Buy	255,990 +189,368	+284%	+$14.3M	0.02%	581
2018 Q2	$4.68M	Hold	66,622	–	–	0.01%	794
2018 Q1	$4.66M	Buy	66,622 +15	+0%	+$1.04K	0.01%	772
2017 Q4	$4.62M	Sell	66,607 -2,578	-4%	-$174K	0.01%	816
2017 Q3	$4.69M	Buy	69,185 +16,000	+30%	+$1.01M	0.01%	822
2017 Q2	$3.63M	Buy	+53,185	New	+$3.47M	﹤0.01%	846
2017 Q1	–	Sell	-38,231	Closed	-$2.09M	–	1861
2016 Q4	$2.09M	Buy	+38,231	New	+$2.17M	﹤0.01%	916

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds's AZN Position: Q1 2019 in Review

OppenheimerFunds increased its AstraZeneca (AZN) stake by 141% in Q1 2019, buying an estimated $94.7M and bringing the position to 2,052,645 shares worth $166M. The position accounts for 0.21% of the portfolio, ranked #111.

OppenheimerFunds first reported a position in AZN in Q4 2016 and has held it in 9 quarters since. 561 funds tracked by Wall St. Rank hold AZN as of Q1 2019.

OppenheimerFunds held 2,052,645 shares of AstraZeneca worth $166M as of Q1 2019.
OppenheimerFunds bought 1,201,960 AstraZeneca shares in Q1 2019, an estimated $94.7M.
AstraZeneca made up 0.21% of OppenheimerFunds's portfolio in Q1 2019, its #111 holding.
OppenheimerFunds first reported a position in AstraZeneca in Q4 2016 and has held it in 9 quarters since.
561 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.